Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex Pharmaceuticals

491.64
+5.421.11%
Post-market: 491.640.00000.00%19:46 EST
Volume:1.15M
Turnover:563.50M
Market Cap:126.25B
PE:-236.37
High:495.54
Open:485.25
Low:483.54
Close:486.22
Loading ...

Vertex Is Maintained at Outperform by Baird

Dow Jones
·
28 Feb

Morgan Stanley Sticks to Their Buy Rating for Vertex (VERX)

TIPRANKS
·
28 Feb

Vertex Receives Chmp Positive Opinion for Expanded Label for Kaftrio® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations

THOMSON REUTERS
·
28 Feb

Vertex Receives CHMP Positive Opinion for Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis to Include Rare Mutations

Business Wire
·
28 Feb

Ema's Chmp: Extending Therapeutic Indication of Kaftrio, Kalydeco for Cystic Fibrosis in Patients Aged 2 Yrs and Older With Certain Cftr Mutations

THOMSON REUTERS
·
28 Feb

Vertex Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
28 Feb

Morgan Stanley Lowers Price Target on Vertex to $57 From $62, Keeps Overweight Rating

MT Newswires Live
·
28 Feb

Vertex Minerals Ltd. Announces Quotation of New Securities on ASX

TIPRANKS
·
28 Feb

Vertex Minerals Converts Loan to Shares, Strengthening Financial Position

TIPRANKS
·
28 Feb

Vertex Inc (VERX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com
·
28 Feb

JMP Securities Keeps Their Buy Rating on Vertex (VERX)

TIPRANKS
·
28 Feb

Vertex, Inc. Reports Strong Revenue Growth in 2024

TIPRANKS
·
28 Feb

Vertex Minerals Begins Gold Concentrate Sales Amid Plant Commissioning

TIPRANKS
·
28 Feb

Vertex, Inc. Earnings Call Highlights Strong Growth

TIPRANKS
·
28 Feb

Vertex readying for maiden gold sale but processing issues spook investors

The Market Herald
·
28 Feb

Vertex downgraded to Hold from Buy at Stifel

TIPRANKS
·
28 Feb